Friday, June 02, 2017 5:32:55 PM
We have 8 or 9 trading days to see this above .01, which will take away a major part of the argument for allowing a RS. I suspect many were against it, thus the 2 week adjournment to see what to do strategically. We need to get this back to .08-.10 without any RS, and when the sector gains force later this year, they can get conventional financing, or if necessary, do an equity issuance. If they can get this back to .08-.10, they could raise a great deal of capital selling then discounted shares at .05-.06.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM